CEO Nick Deeter says that 95% of children continue to receive adult orthopedic products that were never intended for them nor cleared by FDA for use in children. WishBone seeks to change the paradigm of pediatric orthopedics with its child-focused implants and sterile packaged disposable kits.
Paragon 28 expanded its foot and ankle specific portfolio with introduction of the Phantom® ActivCore Hindfoot Nail. The PRECISION® Guided ActivCore Nail addresses a tibio-talo-calcaneal arthrodesis. It is the second of four hindfoot fusion nailing systems that the company plans to launch in 2020. The first was the Phantom Hindfoot TTC/TC System....
Conventus Orthopaedics expanded into lower extremity orthopedics with an acquisition of all assets of IntraFuse, including proprietary intramedullary implants for the minimally invasive repair of fibula and other fractures.
Preliminary study results indicate that X-BOLT Orthopaedics' X-BOLT device for hip fracture repair demonstrated a cut-out rate of 0.8% in a population of 476 patients, and performed as well as a hip sliding screw in measures such as quality of life, mortality, revision, etc.
Results from a retrospective, multicenter study with Treace Medical's Lapiplasty® 3D Bunion Correction procedure revealed a 96.8% maintenance of 3-plane correction at 13.5-month follow-up with an early weight-bearing protocol.
In August 2014, we published a list of companies that we thought were at the forefront of fracture repair. Were we right-that they were worthy of watching? How have they fared since then? We searched funding, regulatory clearance and product launch announcements over the past four years to demonstrate thier activity. Let's recap!
Extremity Medical's 2018 product launches will include the Omni foot plating system, AlignX lateral plates for tibiotalar and tibiotalar-calcaneus fusion, Charcot-specific plates and the Freedom next-gen fixation system.
In 1H17, 23 orthopaedic companies from 11 countries received their first 510(k), according to FDA. We call your attention to these companies to assist you with identifying startups, as well as ex-U.S. companies entering the U.S. market.
Conventus Orthopaedics completed a US $20MM equity financing. Funds will support commercialization of proximal humerus fracture repair technology and the development of the Conventus Cage™ intramedullary implant.
Independent study results indicate comparable clinical outcomes with the use of generic vs. conventional orthopaedic trauma implants, with savings averaging US $1,197 per case. Generic implants were provided by The Orthopaedic Implant Company.
DePuy Synthes announced the availability of Expert Tibial Nail PROtect, featuring a resorbable antibiotic coating designed to provide protection from bacterial colonization in patients at high risk of infection.
Stryker acquired Stanmore Implants Worldwide in an all-cash transaction for £35.6MM (~US $52MM). Stanmore Implants' portfolio comprises patient-specific and off-the-shelf implant systems for limb salvage.
Bio2 Technologies received FDA 510(k) clearance to market a fusion system for interphalangeal fusion, fracture repair and osteotomies of toes, fingers and other small bones. Limited product launch is slated for 2Q16.